In this episode, Nathalie Niddam and Dr. Yurth unpack the challenges of navigating conflicting aging research and highlight the importance of clinical testing as a proving ground for longevity drugs. Additionally, they explore the fascinating world of drug repurposing, discussing how medications like Low-Dose Naltrexone can address a variety of health conditions. Nathalie & Dr. Yurth examine the growing impact of weight loss drugs and their implications for long-term health. Finally, Dr. Yurth touches on the broader conversation around cellular health, its role in longevity, and how to make informed choices in your health journey.
Whether you’re a longevity enthusiast, a healthcare professional, or simply someone interested in the latest advancements in anti-aging science, this episode offers practical insights and cutting-edge knowledge to help you thrive.
This episode is for you if:
– You want to discover the benefits and risks of antioxidants, how to cycle supplements effectively, and the tools to measure biological aging and enhance cellular health.
– You’re curious about the latest advancements in aging research and want to cut through the biases and discrepancies to uncover actionable insights.
– You’re eager to explore groundbreaking treatments like Low-Dose Naltrexone and Tessafensin and learn how they can impact health and longevity.
– You want to hear from an expert in regenerative & cellular medicine.
In this episode of Open Your Eyes Podcast, Dr. Yurth & Nathalie discuss:
✅ Aging Research Insights: Understand biases and discrepancies in longevity studies.
✅ Breakthrough Treatments: Discover innovative drugs like Low-Dose Naltrexone and Tessafensin.
✅ Health Optimization: Get practical advice on stress-free living and evaluating supplements.
🎧 Click below to tune in to Unlocking Lifelong Vitality with Dr. Elizabeth Yurth: Myths, Medicine & Longevity | Ep #241
Interested in learning more about how you can improve your health & longevity with cellular medicine? Get started here with Boulder Longevity Institute.
